| |
| |
|
| Insider
Information: |
Schwartz Jonathan David |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
172,413 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,999,982 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
172,413 |
|
|
| Total
Value |
$3,999,982 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 2.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rocket Pharmaceuticals |
RCKT |
|
2024-03-25 |
172,413 |
|
0 |
Premium* |
|
|
Tabula Rasa Healthcare, Inc. |
TRHC |
|
2023-11-03 |
0 |
2022-09-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• – – |
2024-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
172,413 |
|
% |
|
| TRHC |
Tabula Rasa Healthcare, I... |
|
– • – |
2023-11-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(78,388) |
0 |
0 |
- |
|
| TRHC |
Tabula Rasa Healthcare, I... |
|
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,641 |
78,388 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-02-17 |
4 |
S |
$19.06 |
$67,796 |
D/D |
(3,557) |
94,546 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2023-02-14 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,574 |
98,103 |
0 |
- |
|
| TRHC |
Tabula Rasa Healthcare, I... |
|
– • – |
2022-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
52,747 |
52,747 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2022-04-01 |
4/A |
AS |
$15.86 |
$724,589 |
D/D |
(45,000) |
89,529 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2022-03-31 |
4/A |
AS |
$15.90 |
$724,500 |
D/D |
(45,000) |
134,529 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
See Remarks |
• • – |
2022-03-30 |
4 |
AS |
$15.94 |
$738,652 |
D/D |
(45,000) |
179,529 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
Chief Medical Officer |
• • – |
2021-02-01 |
4 |
OE |
$1.21 |
$277,166 |
D/D |
224,529 |
224,529 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
